Jesús Miranda Poma

Jesús Miranda Poma

FACULTATIVO ESPECIALISTA ONCOLOGÍA MÉDICA
Oncología Médicaes/especialidades/oncologia-medica
Ver más especialistas en Madridmadrid

es/cuadro-medico/oncologo

Datos destacados

  • Última publicación:
    Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors.

Datos del profesional

Hospital Quirónsalud Sur
FACULT. ESP. ONCOLOGÍA MÉDICA
Enero 2020 - Actualidad
Different outcomes among patients with intermediate-risk metastastic renal cell carcinoma treated with first-line tyrosine-kinase inhibitors.
Journal Article
MiRNAs in renal cell carcinoma.
Journal Article, Review
Proteomics Characterization of Clear Cell Renal Cell Carcinoma.
Journal Article
Usefulness and real-world outcomes of next generation sequencing testing in patients with cancer: an observational study on the impact of selection based on clinical judgement.
Journal Article